 |
|
| Blog results | Results 1 - 10 of about 4,315 for bristol myers plavix. (0.26 seconds) |
| Sorted by relevance Sort by date |
| 9 Dec 2009 by insider According to the complaint, Bristol-Myers entered into a settlement in 2006 that allowed Apotex, based in Weston, Ontario, to make a generic version of Plavix. The investors claimed Bristol-Myers didn't disclose that, as part of the ... PharmaGossip - http://pharmagossip.blogspot.com/ - References [ More results from PharmaGossip ] |
| 8 Dec 2009 found 24 h ago on news.google.com. IP Newsflash - intellectual property news... - http://www.ipnewsflash.com/ |
| 19 Nov 2009 After issuing an Early Communication in January about possible drug interactions involving Plavix, the FDA requested new studies from the drug's manufacturers, sanofi-aventis and Bristol-Myers-Squibb. These new studies support the ... GluvSnap.com - http://www.gluvsnap.com/news/ |
| 17 Nov 2009 ORLANDO, Florida (Reuters) - Aspirin alone proved as effective as aspirin plus the blood clot preventer Plavix in keeping coronary artery bypass grafts open during the first year after surgery, according to a study released on Monday. ... BioSpace.com Featured News and Stories - http://www.biospace.com/ [ More results from BioSpace.com Featured News and Stories ] |
| 6 Dec 2009 by Neurodoc Sanofi-aventis and Bristol-Myers Squibb, the makers of Plavix (clopidogrel), are updating this drug's label with the details of the studies and are conducting follow-up studies to further explore drug interactions with clopidogrel. ... Stroke Notes - http://strokenotes.blogspot.com/ |
| 23 Nov 2009 by admin Health News about Scientific American Sanofi, Bristol's Plavix Ads May Have Affected Price Bloomberg Nov. 23 (Bloomberg) -- Sanofi-Aventis SA and Bristol-Myers Squibb Co.'s best-selling blood thinner Plavix may have cost US taxpayers ... NATURAL HEALTH LIFE SOURCE - http://healthlifesource.com/ |
| 6 Apr 2009 ... senior executive of Bristol-Myers Squibb Company (BMS), Andrew Bodnar, pleaded guilty for his role in BMS's dishonest dealings with the federal government relating to a patent deal involving the popular blood-thinning drug Plavix, ... Antitrust Division: Press Releases - http://www.usdoj.gov/atr/public/press_releases/2009/index09.htm |
| 24 Nov 2009 by Ed Silverman Bristol-Myers and Sanofi have raised the price of this necessary medication (for cardiac stent patients) unmercilessly for over 10 years. WE taxpayers pay for over 40% of all Plavix in the U.S. via Medicare/Medicaid/ VA/ DOD - why ... Pharmalot - http://www.pharmalot.com/ [ More results from Pharmalot ] |
| 23 Nov 2009 Sanofi, Bristol's Plavix Ads May Have Affected Price Bloomberg - 22 minutes ago. By Catherine Larkin Nov. 23 (Bloomberg) -- Sanofi-Aventis SA and Bristol-Myers Squibb Co.'s best-selling blood thinner Plavix may have cost US taxpayers ... Pharmainfo.net - http://www.pharmainfo.net/ |
| 23 Nov 2009 by Zacks Market Commentaries Plavix, the antiplatelet blood thinner indicated to reduce the risk of heart attack in patients with atherosclerosis, is the top growth driver for Bristol. However, patent expirations loom large on the company starting 2011 when the ... Stock Market News & Stocks to Watch from... - http://www.straightstocks.com/ [ More results from Stock Market News & Stocks to Watch from... ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
